The role of modulation of antioxidant enzyme systems in the treatment of neurodegenerative diseases (Q38889475)

7 September 2017

1 reference

title

The role of modulation of antioxidant enzyme systems in the treatment of neurodegenerative diseases (English)

1 reference

Sybil Akua Okyerewa Obuobi

7 September 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27389167 AND SRC:MED&resulttype=core&format=json

10 June 2020

Christina L.L. Chai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27389167 AND SRC:MED&resulttype=core&format=json

10 June 2020

Pui Lai Rachel Ee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27389167 AND SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Sanzhar Karatayev

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27389167 AND SRC:MED&resulttype=core&format=json

10 June 2020

Peter Mátyus

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27389167 AND SRC:MED&resulttype=core&format=json

10 June 2020

publication date

7 July 2016

1 reference

Journal of Enzyme Inhibition and Medicinal Chemistry

7 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27389167 AND SRC:MED&resulttype=core&format=json

10 June 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27389167 AND SRC:MED&resulttype=core&format=json

10 June 2020

issue

sup3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27389167 AND SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

194-204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27389167 AND SRC:MED&resulttype=core&format=json

Modulation of mitochondrial dysfunction in neurodegenerative diseases via activation of nuclear factor erythroid-2-related factor 2 by food-derived compounds

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Oxidative damage is the earliest event in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Role of Nrf2 in oxidative stress and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Vacuolar leukoencephalopathy with widespread astrogliosis in mice lacking transcription factor Nrf2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Nrf2-mediated protection against 6-hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Oxidative Toxicity in Neurodegenerative Diseases: Role of Mitochondrial Dysfunction and Therapeutic Strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Pistachio (Pistacia vera L.) gum: a potent inhibitor of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Protein Nitration in Parkinsonʼs Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Nitration of tau protein is linked to neurodegeneration in tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Free radicals and the regulation of mammalian cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Superoxide and hydrogen peroxide in relation to mammalian cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Antioxidant activity of food constituents: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Biological and physiological role of reactive oxygen species--the good, the bad and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Dissecting the role of redox signaling in neuronal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Redox homeostasis: the linchpin in stem cell self-renewal and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Oxidative Stress, Mitochondrial Dysfunction, and Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease--therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Synthesis and characterization of semi-interpenetrating polymer networks based on polyurethane and N-isopropylacrylamide for wound dressing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Phytochemical modulators of mitochondria: the search for chemopreventive agents and supportive therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Mechanism of oxidative stress in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Impaired balance of mitochondrial fission and fusion in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

The Impact of Mitochondrial Fusion and Fission Modulation in Sporadic Parkinson's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Hydrogen peroxide produced by mitochondrial monoamine oxidase catalysis: biological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Nitric oxide synthases: structure, function and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Blockade of presynaptic adenosine A1 receptor responses by nitric oxide and superoxide in rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

NOX enzymes in the central nervous system: from signaling to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Mechanistic studies of the Nrf2-Keap1 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Distinct Cysteine Residues in Keap1 Are Required for Keap1-Dependent Ubiquitination of Nrf2 and for Stabilization of Nrf2 by Chemopreventive Agents and Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Keap1, the sensor for electrophiles and oxidants that regulates the phase 2 response, is a zinc metalloprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Sites of alkylation of human Keap1 by natural chemoprevention agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Activation of Nrf2 by arsenite and monomethylarsonous acid is independent of Keap1-C151: enhanced Keap1-Cul3 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Cysteine-based regulation of the CUL3 adaptor protein Keap1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Crystal structure of the Kelch domain of human Keap1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a "tethering" mechanism: a two-site interaction model for the Nrf2-Keap1 complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Structural basis of Keap1 interactions with Nrf2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Phosphatidylinositol 3-kinase, not extracellular signal-regulated kinase, regulates activation of the antioxidant-responsive element in IMR-32 human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Nrf2/ARE pathway activation, HO-1 and NQO1 induction by polychlorinated biphenyl quinone is associated with reactive oxygen species and PI3K/AKT signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK-3beta: connecting neurotransmission with neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Diabetic Downregulation of Nrf2 Activity via ERK Contributes to Oxidative Stress–Induced Insulin Resistance in Cardiac Cells In Vitro and In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Src Subfamily Kinases Regulate Nuclear Export and Degradation of Transcription Factor Nrf2 to Switch Off Nrf2-mediated Antioxidant Activation of Cytoprotective Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/β-TrCP axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: Role of glycogen synthase kinase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Antioxidant and radical scavenging properties of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Resveratrol Preconditioning Protects Against Cerebral Ischemic Injury via Nuclear Erythroid 2-Related Factor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Resveratrol as a Potential Therapeutic Candidate for the Treatment and Management of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

A potential role of the curry spice curcumin in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Puerarin attenuates neuronal degeneration and blocks oxidative stress to elicit a neuroprotective effect on substantia nigra injury in 6-OHDA-lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Gastrodin prevents motor deficits and oxidative stress in the MPTP mouse model of Parkinson's disease: involvement of ERK1/2-Nrf2 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Keap1 cysteine 288 as a potential target for diallyl trisulfide-induced Nrf2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Amelioration of Alzheimer's disease by neuroprotective effect of sulforaphane in animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Allicin ameliorates cognitive deficits ageing-induced learning and memory deficits through enhancing of Nrf2 antioxidant signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Allicin improves endoplasmic reticulum stress-related cognitive deficits via PERK/Nrf2 antioxidative signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Decaffeinated coffee and nicotine-free tobacco provide neuroprotection in Drosophila models of Parkinson's disease through an NRF2-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Synthetic oleanane and ursane triterpenoids with modified rings A and C: a series of highly active inhibitors of nitric oxide production in mouse macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Triterpenoid CDDO-Me blocks the NF-kappaB pathway by direct inhibition of IKKbeta on Cys-179.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-kappaB activation through direct inhibition of IkappaB kinase beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Bardoxolone brings Nrf2-based therapies to light

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Synthetic chalcones with potent antioxidant ability on H₂O₂-induced apoptosis in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

The Cytoprotective Effects of E-α-(4-Methoxyphenyl)-2',3,4,4'-Tetramethoxychalcone (E-α-p-OMe-C6H4-TMC)--A Novel and Non-Cytotoxic HO-1 Inducer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Carbon monoxide: an unusual drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Diverse Nrf2 Activators Coordinated to Cobalt Carbonyls Induce Heme Oxygenase-1 and Release Carbon Monoxide in Vitro and in Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Chalcones: an update on cytotoxic and chemoprotective properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

A review of anti-infective and anti-inflammatory chalcones

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Structure-activity relationships of methoxychalcones as inducers of heme oxygenase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Structural requirements of 2',4',6'-tris(methoxymethoxy) chalcone derivatives for anti-inflammatory activity: the importance of a 2'-hydroxy moiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Heterocyclic chalcone activators of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) with improved in vivo efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14756366.2016.1205047

10.1080/14756366.2016.1205047

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27389167 AND SRC:MED&resulttype=core&format=json

release_x67qrn7vbbgipdjkhx3mcfqooq

10 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/x67qrn7vbbgipdjkhx3mcfqooq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference